Johnson & JohnsonJNJ

Where JNJ's Net Debt / EBITDA sits inside its own 10-year distribution, with the yearly high, low and average.

$278.43+3.22 (+1.17%)Previous close
NYSEHealthcareDividend King

JNJ Net Debt / EBITDA: current value, 10-year range and year-by-year history

Net Debt / EBITDA History

Historically priceyAbove avgAround avgBelow avgHistorically cheap
JNJ Net Debt / EBITDA historyJNJ Net Debt / EBITDA from Oct 2023 to Jun 2026: low 0.29, high 0.99, latest 0.85.0.230.440.640.851.05Oct 23Mar 24Sep 24Jun 25Dec 25Jun 26med 0.6

JNJ Net Debt / EBITDA by year

Yearly range of JNJ’s net debt / ebitda from 2016 to 2026. Over the full period it ranged from 0.3 to 1.6, averaging 0.7.

JNJ Net Debt / EBITDA — yearly low, average, high and year-end values
YearLowAverageHighYear-end
20260.80.91.00.8
20250.40.70.90.7
20240.30.50.60.5
20230.30.91.60.3
20220.70.80.90.9
20210.60.70.80.6
20200.50.70.90.9
20190.40.50.60.4
20180.50.60.70.5
20170.50.70.90.7
20160.30.40.40.3

Get notified when JNJ Net Debt / EBITDA crosses a threshold

Free — one alert setup, notifications by push, Telegram, or Discord.

How many years of operating earnings it would take to pay off the company's net debt. The most common leverage ratio — higher means more financial risk and less flexibility.

Formula(Total Debt − Cash) / EBITDA
Full guide
How to read this chart

Watch the trend more than the level. Declining ratio = deleveraging, growing financial flexibility. Rising ratio = increasing leverage, which constrains dividends, buybacks, and future investment.

Key caveats
  • Sector context is essential: 3× is aggressive for a consumer brand but normal for a regulated utility. Always compare to sector peers.
  • Large acquisitions spike the ratio temporarily — check whether the integration plan credibly drives paydown.
Pro — up to 30-year history

Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.